Chronic Hepatitis C- Swedish Experts' Meeting Recommends Combination Treatment

Abstract

Additional participants in the experts' meeting: Jane Ahlqvist-Rastad, Swedish Medical Products Agency, Uppsala, Sweden; Jan Albert, Department of Virology, Swedish Institute for Infectious Disease Control, Stockholm, and the Swedish Reference Group for Antiviral Therapy (RAV); Jan Andersson, Division of Infectious Diseases, Karolinska Institutet, Huddinge Hospital, Stockholm, and RAV; Björn Beermann, Swedish Medical Products Agency, Uppsala, Sweden; Ann-Britt BohlinWiechel, Department of Pediatrics, Karolinska Institutet, Huddinge Hospital, Stockholm, and RAV; Jean Henrik Braconier, Department of Infectious Diseases, Lund University Hospital, Lund; Ulrika Broomé, Department of Gastroenterology, Karolinska Institutet, Huddinge Hospital, Stockholm; Ake Danielsson, Department of Gastroenterology, University Hospital, Umeå; Ann-Sofi Duberg, Department of Infectious Diseases, Örebro Hospital, Örebro; Aril Frydén, Department of Infectious Diseases, University Hospital, Linköping; Ingegerd Hökeberg, Department of Infectious Diseases, University Hospital, Uppsala; Stefan Lindgren, Department of Gastroenterology, Malmö University Hospital, Malmö; Susanne Lindgren, Department of Obstetrics and Gynaecology, Karolinska Institutet, Huddinge Hospital, and RAV; Lars Lööf, Department of Gastroenterology, University Hospital, Uppsala; Lars Mattsson, Division of Infectious Diseases, Karolinska Institutet, Huddinge Hospital, Stockholm; Lars Ståhle, Department of Clinical Pharmacology, Karolinska Institutet, Huddinge Hospital, Stockholm, and RAV; Anders Widell, Department of Clinical Virology, MalmöUniversity Hospital, Malmö; Johan Wiströ